News

Otsuka and Avanir to Help Start an Alzheimer’s Assistants Training Program in New Jersey

Otsuka America Pharmaceutical and Avanir Pharmaceuticals are working with southern New Jersey educational administrators to create specialists who can help Alzheimer’s patients and their families navigate the care continuum. The goal is to start a one-year training program at Camden County College that leads to a specialist’s certification. Those receiving…

Seizure-Like Brain Activity May Contribute to Alzheimer’s Development, Study Reports

Epileptic-seizure-like activity in a brain region called the hippocampus may contribute to the development of Alzheimer’s, according to a case study involving two patients. And an anti-epileptic medicine may be able to slow the disease’s progression, Massachusetts General Hospital researchers said. An additional finding was that seizure-like activity may be difficult to…

Preventing Diabetes May Help Halt Alzheimer’s Progression in New York State, Report Says

The state of New York lacks effective measures for preventing diabetes, which is fueling a dramatic increase in Alzheimer’s disease. So says a new document, “Unprevented Diabetes Means Unnecessary Alzheimer’s,” issued by Health People: Community Preventive Health Institute. Doctors say diabetes increases the risk of getting Alzheimer’s by 40 percent. Currently, New York state…

AFFIRMATIVhealth Uses Latest Research to Create or Update Personalized Alzheimer’s Treatment Plan

A special issue of PLOS Medicine that covers a broad range of new Alzheimer’s and dementia studies underscores the importance of a holistic, personalized-care approach to treatment, according to a California health care provider that promotes that approach. AFFIRMATIVhealth uses information from the latest research on these neurodegenerative conditions to…